兆科眼科有限公司（股票代码：06622，简称“兆科眼科-B”）于2026年5月5日发布截至2026年4月30日的股份变动月报表。根据公告，公司截至本月末的股本结构与上月底相比保持不变。
公告显示，兆科眼科-B的法定/注册股本仍为1,600,000,000,000股普通股，每股面值USD 0.00000025，法定/注册股本总额USD 400,000。于4月30日，公司已发行的普通股数量维持在548,749,012股，库藏股数量为0股，均与上月底一致。公司同时确认符合香港联交所的最低公众持股量要求。
在股权激励方面，公司列明多项首次公开发售前及公开发售后购股权计划。截至报告期末，相关期权结存数分别为24,447,016份、4,926,000份、3,890,000份及8,000,000份，未有新股发行及库藏股转让。报告期未发生任何股份回购或注销行为，股本结构保持稳定。
兆科眼科-B在公告中同时声明，所有涉及本月股份及期权的相关事项均按上市规则及法律法规办理，已获董事会正式审批。公告由公司董事李小羿签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.